Method of modulating IL-6

Details for Australian Patent Application No. 2004204261 (hide)

Owner Solbec Pharmaceuticals Limited

Inventors Carter, Stephen John; Lake, Richard

Agent Wrays

Pub. Number AU-A-2004204261

PCT Pub. Number WO2004/062675

Priority 2003900194 15.01.03 AU

Filing date 15 January 2004

Wipo publication date 29 July 2004

International Classifications

A61K 031/706

A61K 031/7048

A61K 031/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 035/00 Antineoplastic agents

A61P 025/00 Drugs for disorders of the nervous system

A61P 017/12 Drugs for dermatological disorders

A61P 017/02 Drugs for dermatological disorders

A61P 017/00 Drugs for dermatological disorders

A61P 015/00 Drugs for genital or sexual disorders

A61P 015/16 Drugs for genital or sexual disorders

A61P 015/08 Drugs for genital or sexual disorders

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/062675 Priority application(s): WO2004/062675

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204262-Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen

2004204259-Dispenser device